| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2002PNAS...99.8932H |
| P356 | DOI | 10.1073/PNAS.132252399 |
| P932 | PMC publication ID | 124401 |
| P698 | PubMed publication ID | 12084934 |
| P5875 | ResearchGate publication ID | 11290326 |
| P2093 | author name string | Edwin M Horwitz | |
| Linda Muul | |||
| Michael D Neel | |||
| Patricia L Gordon | |||
| Jeffrey C Marx | |||
| Ted Hofmann | |||
| Rene Y McNall | |||
| Winston K K Koo | |||
| P2860 | cites work | Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases | Q73180485 |
| Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy | Q73358706 | ||
| Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age | Q73866982 | ||
| Intravenous pamidronate treatment in osteogenesis imperfecta | Q73916090 | ||
| Adult rat and human bone marrow stromal cells differentiate into neurons | Q28142919 | ||
| Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo | Q29619355 | ||
| Postnatal development of bone mineral status during infancy | Q32112309 | ||
| Bone marrow transplantation as effective treatment of central nervous system disease in globoid cell leukodystrophy, metachromatic leukodystrophy, adrenoleukodystrophy, mannosidosis, fucosidosis, aspartylglucosaminuria, Hurler, Maroteaux-Lamy, and S | Q33607275 | ||
| Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome | Q33765215 | ||
| Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta | Q33855709 | ||
| Cyclic administration of pamidronate in children with severe osteogenesis imperfecta | Q34067536 | ||
| Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice | Q34269619 | ||
| Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow | Q35107753 | ||
| Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. | Q36894740 | ||
| High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells | Q40812546 | ||
| Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. | Q41268880 | ||
| Physical growth: National Center for Health Statistics percentiles | Q41435134 | ||
| Bone marrow transplantation for inherited diseases | Q41479760 | ||
| Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone | Q41552587 | ||
| Continuously growing bipotential and monopotential myogenic, adipogenic, and chondrogenic subclones isolated from the multipotential RCJ 3.1 clonal cell line | Q41711691 | ||
| Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease | Q45863206 | ||
| Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model | Q45870043 | ||
| Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta | Q45875073 | ||
| Osteogenesis imperfecta. Rehabilitation and prospects for gene therapy | Q45880744 | ||
| Muscle regeneration by bone marrow-derived myogenic progenitors | Q45885806 | ||
| Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy | Q46549703 | ||
| Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells | Q48000642 | ||
| In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. | Q50525701 | ||
| Dystrophin expression in the mdx mouse restored by stem cell transplantation. | Q52174025 | ||
| Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H-2Kb-tsA58 transgenic mouse. | Q52201430 | ||
| Retroviral vectors | Q60160345 | ||
| Characterization of cells with osteogenic potential from human marrow | Q68117980 | ||
| Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo | Q70179983 | ||
| Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures | Q72288052 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteogenesis imperfecta | Q749409 |
| bone marrow | Q546523 | ||
| P304 | page(s) | 8932-8937 | |
| P577 | publication date | 2002-06-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone | |
| P478 | volume | 99 |
| Q43897756 | "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). |
| Q53002605 | 3D-Printed Atsttrin-Incorporated Alginate/Hydroxyapatite Scaffold Promotes Bone Defect Regeneration with TNF/TNFR Signaling Involvement. |
| Q44666580 | A comparison of allogeneic and autologous mesenchymal stromal cells and osteoprogenitor cells in augmenting bone formation around massive bone tumor prostheses |
| Q42478318 | A comprehensive characterization study of human bone marrow mscs with an emphasis on molecular and ultrastructural properties |
| Q39106216 | A doxycycline inducible, adenoviral bone morphogenetic protein-2 gene delivery system to bone |
| Q33286115 | A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cells |
| Q41436589 | A novel composition for the culture of human adipose stem cells which includes complement C3 |
| Q34072165 | A novel human TGF-β1 fusion protein in combination with rhBMP-2 increases chondro-osteogenic differentiation of bone marrow mesenchymal stem cells. |
| Q92028449 | A novel protocol for isolation and culture of multipotent progenitor cells from human urine |
| Q39298233 | A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion |
| Q46170497 | A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow |
| Q36634299 | A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction |
| Q26998969 | A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods |
| Q41882050 | A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells |
| Q59310818 | A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon α/β |
| Q47972581 | Activation and Differentiation of Mesenchymal Stem Cells |
| Q39341467 | Adipose Tissue Derived Multipotent Mesenchymal Stromal Cells Can Be Isolated Using Serum-free Media. |
| Q37124789 | Adipose-Derived Regenerative Cell Injection Therapy for Postprostatectomy Incontinence: A Phase I Clinical Study |
| Q37092184 | Adipose-derived cells |
| Q38176442 | Adult adherent stromal cells in the management of graft-versus-host disease |
| Q36904778 | Adult bone marrow-derived stem cells for organ regeneration and repair |
| Q80809916 | Adult bone-marrow stem cells and their potential in medicine |
| Q51839817 | Adult human bone marrow-derived mesenchymal progenitor cells are capable of adhesion-independent survival and expansion. |
| Q30010227 | Adult mesenchymal stem cells and cell surface characterization - a systematic review of the literature |
| Q36616760 | Adult mesenchymal stem cells in dental research: a new approach for tissue engineering |
| Q35921537 | Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. |
| Q37157668 | Adult mesenchymal stromal stem cells for therapeutic applications |
| Q35837725 | Adult stem cell plasticity: will engineered tissues be rejected? |
| Q94018218 | Advances in Single-cell Tracking of Mesenchymal Stem Cells (MSCs) During Musculoskeletal Regeneration |
| Q41906508 | Advances in bone marrow-derived cell therapy: CD31-expressing cells as next generation cardiovascular cell therapy |
| Q39178219 | Alkaline phosphatase expression/activity and multilineage differentiation potential are the differences between fibroblasts and orbital fat-derived stem cells--a study in animal serum-free culture conditions |
| Q37119320 | Allele dependent silencing of collagen type I using small interfering RNAs targeting 3'UTR Indels - a novel therapeutic approach in osteogenesis imperfecta |
| Q41060784 | Allogeneic Mesenchymal Stem Cell Treatment Induces Specific Alloantibodies in Horses. |
| Q35953269 | Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products |
| Q33958410 | Amelioration of a mouse model of osteogenesis imperfecta with hematopoietic stem cell transplantation: microcomputed tomography studies |
| Q38187412 | Amniotic fluid stem cells and their application in cell-based tissue regeneration |
| Q42622440 | An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies |
| Q59050655 | Application of Nanoscaffolds in Mesenchymal Stem Cell-Based Therapy |
| Q64096311 | Application of a Bioactive/Bioresorbable Three-Dimensional Porous Uncalcined and Unsintered Hydroxyapatite/Poly-D/L-lactide Composite with Human Mesenchymal Stem Cells for Bone Regeneration in Maxillofacial Surgery: A Pilot Animal Study |
| Q34735725 | Application of stem cells in bone repair |
| Q42542660 | Application of stem cells in orthopedics |
| Q27307048 | Architectural and mechanical cues direct mesenchymal stem cell interactions with crosslinked gelatin scaffolds |
| Q53394910 | Are mesenchymal stromal cells from children resistant to apoptosis? |
| Q42444018 | Assessment of umbilical cord tissue as a source of mesenchymal stem cell/endothelial cell mixtures for bone regeneration |
| Q36141009 | Association between in vivo bone formation and ex vivo migratory capacity of human bone marrow stromal cells |
| Q58702583 | Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration |
| Q33713800 | Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases |
| Q37837891 | Autologous cell therapy for cardiac repair. |
| Q42229494 | Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial. |
| Q46607429 | Autologous serum enhances cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells in the presence of transforming growth factor-β1 (TGF-β1). |
| Q95841416 | BM-MSC Transplantation Alleviates Intracerebral Hemorrhage-Induced Brain Injury, Promotes Astrocytes Vimentin Expression, and Enhances Astrocytes Antioxidation via the Cx43/Nrf2/HO-1 Axis |
| Q27308865 | Bio-imaging and Photodynamic Therapy with Tetra Sulphonatophenyl Porphyrin (TSPP)-TiO2 Nanowhiskers: New Approaches in Rheumatoid Arthritis Theranostics |
| Q28069791 | Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells |
| Q36056388 | Bioinspired nanofibers support chondrogenesis for articular cartilage repair |
| Q96303206 | Biological Considerations in Scaling Up Therapeutic Cell Manufacturing |
| Q34333323 | Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues |
| Q36437345 | Biological treatment strategies for disc degeneration: potentials and shortcomings |
| Q57930762 | Biomechanical analysis predicts decreased human mesenchymal stem cell function before molecular differences |
| Q35870669 | Biomimetic Surface Patterning Promotes Mesenchymal Stem Cell Differentiation |
| Q38262146 | Biotechnological and biomedical applications of mesenchymal stem cells as a therapeutic system. |
| Q36516556 | Bone marrow and tumour stroma: an intimate relationship |
| Q34271229 | Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art |
| Q45858232 | Bone marrow mesenchymal cells for haemophilia A gene therapy using retroviral vectors with modified long-terminal repeats |
| Q42517934 | Bone marrow stromal cells contribute to bone formation following infusion into femoral cavities of a mouse model of osteogenesis imperfecta. |
| Q35750606 | Bone marrow stromal cells produce long-term pain relief in rat models of persistent pain |
| Q36474301 | Bone marrow stromal stem cells for tissue engineering. |
| Q34996070 | Bone marrow transplantation for non-malignant disease |
| Q73042705 | Bone marrow transplantation: it's not just about blood anymore! |
| Q36922408 | Bone marrow-derived stem cells in wound healing: a review |
| Q38025402 | Bone regeneration with mesenchymal stem cells. |
| Q35216061 | Bone regeneration: stem cell therapies and clinical studies in orthopaedics and traumatology |
| Q37617540 | Bone regeneration: the stem/progenitor cells point of view |
| Q26744340 | Bone repair with skeletal stem cells: rationale, progress to date and clinical application |
| Q38200041 | Bone tissue engineering and regenerative medicine: targeting pathological fractures. |
| Q39305939 | Bone-marrow-derived mesenchymal stem cells for organ repair |
| Q26798278 | Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells |
| Q35900953 | Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humans |
| Q42785086 | Building bone from blood vessels |
| Q35629950 | CDH2 and CDH11 act as regulators of stem cell fate decisions |
| Q46831274 | Calcium-incorporated titanium surfaces influence the osteogenic differentiation of human mesenchymal stem cells |
| Q47151493 | Calvarial Suture-Derived Stem Cells and Their Contribution to Cranial Bone Repair. |
| Q34199130 | Cancer stem cells as targets for cancer therapy: selected cancers as examples. |
| Q40525318 | Canine and Equine Mesenchymal Stem Cells Grown in Serum Free Media Have Altered Immunophenotype |
| Q36267790 | Cardiac stem cells and mechanisms of myocardial regeneration |
| Q41367762 | Cardiovascular repair with bone marrow-derived cells |
| Q38235872 | Caveats of mesenchymal stem cell therapy in solid organ transplantation |
| Q39233323 | Cell Therapy for Multiple Sclerosis |
| Q37795949 | Cell Transplantation for Articular Cartilage Defects: Principles of Past, Present, and Future Practice |
| Q37798699 | Cell therapy approaches aiming at minimization of immunosuppression in solid organ transplantation |
| Q35737506 | Cell therapy for disc degeneration--potentials and pitfalls. |
| Q37687140 | Cellular therapy for repair of cardiac damage after acute myocardial infarction |
| Q37220543 | Cellular therapy of systemic sclerosis |
| Q91949725 | Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review |
| Q80337232 | Changes in expression of genes related to cell proliferation in human mesenchymal stem cells during in vitro culture in comparison with cancer cells |
| Q34803754 | Changes in immunological profile of allogeneic mesenchymal stem cells after differentiation: should we be concerned? |
| Q39965298 | Changes in the expression of CD106, osteogenic genes, and transcription factors involved in the osteogenic differentiation of human bone marrow mesenchymal stem cells |
| Q92028456 | Characterisation of multipotent stem cells from human peripheral blood using an improved protocol |
| Q38985015 | Characterization and evaluation of mesenchymal stem cells derived from human embryonic stem cells and bone marrow |
| Q37196107 | Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant? |
| Q37871512 | Circulating osteogenic cells: implications for injury, repair, and regeneration |
| Q36201509 | Circulating osteogenic precursor cells in type 2 diabetes mellitus |
| Q37867953 | Clinical Protocols for the Isolation and Expansion of Mesenchymal Stromal Cells |
| Q38596084 | Clinical Trials With Mesenchymal Stem Cells: An Update. |
| Q38122364 | Clinical applications of mesenchymal stem cells |
| Q30437823 | Clinical applications of mesenchymal stem cells in chronic diseases |
| Q34064517 | Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response |
| Q83973667 | Co-culture of mesenchymal stem cells with umbilical vein endothelial cells under hypoxic condition |
| Q36603453 | Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial |
| Q38432643 | Concise Review: MSC-Derived Exosomes for Cell-Free Therapy |
| Q33722466 | Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements. |
| Q38314852 | Concise Review: Mesenchymal Stem Cells Ameliorate Tissue Injury via Secretion of Tumor Necrosis Factor-α Stimulated Protein/Gene 6. |
| Q47762656 | Concise Review: Musculoskeletal Stem Cells to Treat Age-Related Osteoporosis. |
| Q37128260 | Concise review: adult multipotent stromal cells and cancer: risk or benefit? |
| Q37769501 | Concise review: hitting the right spot with mesenchymal stromal cells |
| Q38063850 | Concise review: immunomodulatory properties of mesenchymal stem cells in cellular transplantation: update, controversies, and unknowns |
| Q37838864 | Concise review: induced pluripotent stem cells and lineage reprogramming: prospects for bone regeneration |
| Q37056276 | Concise review: mesenchymal stem cells and translational medicine: emerging issues. |
| Q36594578 | Concise review: multipotent mesenchymal stromal cells in blood |
| Q38200506 | Concise review: optimizing expansion of bone marrow mesenchymal stem/stromal cells for clinical applications |
| Q36862085 | Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives |
| Q35200156 | Concise review: workshop review: understanding and assessing the risks of stem cell-based therapies |
| Q42501122 | Conditioned Media From Adipose Tissue Derived Mesenchymal Stem Cells Reverse Insulin Resistance in Cellular Models |
| Q39064337 | Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors |
| Q37212195 | Constitutive stabilization of hypoxia-inducible factor alpha selectively promotes the self-renewal of mesenchymal progenitors and maintains mesenchymal stromal cells in an undifferentiated state |
| Q34996387 | Controlled growth and differentiation of MSCs on grooved films assembled from monodisperse biological nanofibers with genetically tunable surface chemistries. |
| Q36712812 | Cord-blood mesenchymal stem cells and tissue engineering |
| Q45882623 | Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects |
| Q31136667 | Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation |
| Q35205677 | Could cancer and infection be adverse effects of mesenchymal stromal cell therapy? |
| Q38134131 | Could mesenchymal stromal cells have a role in childhood autoimmune diseases? |
| Q37000249 | Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy. |
| Q50224283 | Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy? |
| Q41854522 | Culture and Use of Mesenchymal Stromal Cells in Phase I and II Clinical Trials |
| Q44792842 | Culture and differentiation of osteoblasts on coral scaffold from human bone marrow mesenchymal stem cells |
| Q37778124 | Culture media for the differentiation of mesenchymal stromal cells |
| Q39647492 | Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells |
| Q64039618 | Current and Emerging Therapeutic Options for the Management of Rare Skeletal Diseases |
| Q34133308 | Current and emerging treatments for the management of osteogenesis imperfecta. |
| Q37777053 | Current, new and future treatments of osteoporosis |
| Q33810686 | Cysteine: a novel neural inducer for rat bone marrow mesenchymal stem cells |
| Q33669095 | Cytoskeletal changes of mesenchymal stem cells during differentiation |
| Q53818882 | Dental Mesenchymal Stem Cell-Based Translational Regenerative Dentistry: From Artificial to Biological Replacement. |
| Q38120972 | Dental stem cells and their promising role in neural regeneration: an update |
| Q33614886 | Derivation, expansion and characterization of clinical grade mesenchymal stem cells from umbilical cord matrix using cord blood serum |
| Q36065953 | Development of mammalian artificial chromosomes for the treatment of genetic diseases: Sandhoff and Krabbe diseases |
| Q30428895 | Diabetes-associated macrovascular complications: cell-based therapy a new tool? |
| Q90614070 | Differences between the Proliferative Effects of Human Platelet Lysate and Fetal Bovine Serum on Human Adipose-Derived Stem Cells |
| Q34881281 | Different culture media affect growth characteristics, surface marker distribution and chondrogenic differentiation of human bone marrow-derived mesenchymal stromal cells |
| Q34510799 | Differential expression of surface markers in mouse bone marrow mesenchymal stromal cell subpopulations with distinct lineage commitment |
| Q37435735 | Differentiating human multipotent mesenchymal stromal cells regulate microRNAs: prediction of microRNA regulation by PDGF during osteogenesis |
| Q50496496 | Differentiation of bone marrow-derived cells into regenerated mesothelial cells in peritoneal remodeling using a peritoneal fibrosis mouse model. |
| Q44388205 | Differentiation of human bone marrow-derived cells into buccal epithelial cells in vivo: a molecular analytical study |
| Q73701973 | Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med,low phenotype |
| Q40097346 | Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. |
| Q37472831 | Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells? |
| Q35240062 | Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties? |
| Q36528817 | Donor cell-derived osteopoiesis originates from a self-renewing stem cell with a limited regenerative contribution after transplantation |
| Q35849125 | Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting |
| Q34424242 | Dystrophin conferral using human endothelium expressing HLA-E in the non-immunosuppressive murine model of Duchenne muscular dystrophy |
| Q37591306 | ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective |
| Q42292968 | Early outgrowth cells release soluble endocrine antifibrotic factors that reduce progressive organ fibrosis |
| Q34698972 | Effect of Intra-Medullar and Intra-Venous Infusions of Mesenchymal Stem Cells on Cell Engraftment by In-Vivo Cell Tracking and Osteoinductivity in Rabbit Long Bones: A Pilot Study |
| Q90347092 | Effect of allogeneic platelet lysate on equine bone marrow derived mesenchymal stem cell characteristics, including immunogenic and immunomodulatory gene expression profile |
| Q37720500 | Effect of cyclic mechanical stimulation on the expression of osteogenesis genes in human intraoral mesenchymal stromal and progenitor cells |
| Q53395300 | Effect of mechanical stimulation on the differentiation of cord stem cells. |
| Q48887901 | Effect of mesenchymal stem cell transplantation on the engraftment of human hematopoietic stem cells and leukemic cells in mice model |
| Q37565699 | Effects of ECM protein mimetics on adhesion and proliferation of chorion derived mesenchymal stem cells |
| Q33875634 | Effects of Na/K-ATPase and its ligands on bone marrow stromal cell differentiation |
| Q35304774 | Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells |
| Q36882842 | Effects of epidermal growth factor and basic fibroblast growth factor on the proliferation and osteogenic and neural differentiation of adipose-derived stem cells |
| Q83156126 | Effects of human placental serum on proliferation and morphology of human adipose tissue-derived stem cells |
| Q36861424 | Effects of medium supplements on proliferation, differentiation potential, and in vitro expansion of mesenchymal stem cells |
| Q28305878 | Effects of transplanted mesenchymal stem cells isolated from Wharton's jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation |
| Q34325074 | Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5 |
| Q44143110 | Efficient expansion of mesenchymal stem cells from mouse bone marrow under hypoxic conditions |
| Q33864713 | Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. |
| Q58695589 | Enhanced articular cartilage regeneration with SIRT1-activated MSCs using gelatin-based hydrogel |
| Q42125898 | Enhancement of Glycosaminoglycan-Rich Matrix Production in Human Marrow-Derived Mesenchymal Stem Cell Chondrogenic Culture by Lithium Chloride and SB216763 Treatment |
| Q91911674 | Enhancement of individual differences in proliferation and differentiation potentials of aged human adipose-derived stem cells |
| Q42057790 | Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis |
| Q37698233 | Epidermal growth factor (EGF) treatment on multipotential stromal cells (MSCs). Possible enhancement of therapeutic potential of MSC. |
| Q35109954 | Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation |
| Q35551421 | Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo. |
| Q33453904 | Establishment of a mesenchymal stem cell bank |
| Q52729545 | Evaluation of Peripheral Blood and Cord Blood Platelet Lysates in Isolation and Expansion of Multipotent Mesenchymal Stromal Cells. |
| Q38014437 | Ex vivo expansion of human mesenchymal stem cells in defined serum-free media |
| Q28264546 | Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone |
| Q35168406 | Examining the feasibility of clinical grade CD271+ enrichment of mesenchymal stromal cells for bone regeneration |
| Q51874331 | Expansion and preservation of multipotentiality of rabbit bone-marrow derived mesenchymal stem cells in dextran-based microcarrier spin culture. |
| Q44279374 | Expansion of Bone Marrow Mesenchymal Stromal Cells in Perfused 3D Ceramic Scaffolds Enhances In Vivo Bone Formation |
| Q55400368 | Expression profile of microRNAs following bone marrow-derived mesenchymal stem cell treatment in lipopolysaccharide-induced acute lung injury. |
| Q38180964 | Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages |
| Q90712400 | Fate of systemically and locally administered adipose-derived mesenchymal stromal cells and their effect on wound healing |
| Q46843859 | Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease |
| Q37114094 | Feasibility investigation of allogeneic endometrial regenerative cells |
| Q35673101 | Fetal liver-derived mesenchymal stem cell engraftment after allogeneic in utero transplantation into rabbits |
| Q35097559 | Fibroblast activation protein (FAP) is essential for the migration of bone marrow mesenchymal stem cells through RhoA activation |
| Q64893292 | Fibroblasts as a practical alternative to mesenchymal stem cells. |
| Q36915136 | Further proof for an unpopular concept: a single cell from bone marrow can serve as a stem cell for both hematopoiesis and osteogenesis |
| Q38000390 | Gene delivery to bone |
| Q21263189 | Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation |
| Q24298392 | Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta |
| Q35629569 | Gene therapy approaches for osteogenesis imperfecta |
| Q54407166 | Generation of an osteogenic graft from human placenta and placenta-derived mesenchymal stem cells. |
| Q37065149 | Generation of insulin-producing human mesenchymal stem cells using recombinant adeno-associated virus |
| Q39307647 | Generation of mesenchymal stem cell lines from murine bone marrow. |
| Q52676411 | Global phenotypic characterisation of human platelet lysate expanded MSCs by high-throughput flow cytometry. |
| Q36076501 | Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency |
| Q26765063 | Glycan Engineering for Cell and Developmental Biology |
| Q39645403 | Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage. |
| Q39911635 | Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage |
| Q28251644 | Glycosyltransferase-programmed stereosubstitution (GPS) to create HCELL: engineering a roadmap for cell migration |
| Q39840843 | Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. |
| Q43636691 | HIF-1α is upregulated in human mesenchymal stem cells |
| Q79149793 | HLA expression and immunologic propertiesof differentiated and undifferentiated mesenchymal stem cells |
| Q37811950 | HLA-G in organ transplantation: towards clinical applications |
| Q37355610 | HSCT recipients have specific tolerance to MSC but not to the MSC donor |
| Q37415975 | Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. |
| Q37718660 | Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches |
| Q36443036 | Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche |
| Q47602229 | Heritable Skeletal Disorders Arising from Defects in Processing and Transport of Type I Procollagen from the ER: Perspectives on Possible Therapeutic Approaches |
| Q42742754 | Heterogeneity of engrafted bone-lining cells after systemic and local transplantation |
| Q34576952 | High throughput transcriptome profiling of lithium stimulated human mesenchymal stem cells reveals priming towards osteoblastic lineage |
| Q84689154 | Highly efficient osteogenic differentiation of human mesenchymal stem cells by eradication of STAT3 signaling |
| Q34475885 | Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cells |
| Q37788681 | Homing Pathways of Mesenchymal Stromal Cells (MSCs) and Their Role in Clinical Applications |
| Q26750318 | Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? |
| Q37867955 | Homing of Mesenchymal Stem Cells |
| Q36167459 | How Wnt signaling affects bone repair by mesenchymal stem cells from the bone marrow |
| Q52668325 | How to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive. |
| Q35814737 | Human Adipose-Derived Mesenchymal Stem Cells in Cell Therapy: Safety and Feasibility in Different "Hospital Exemption" Clinical Applications |
| Q38688638 | Human Allogeneic Bone Marrow and Adipose Tissue Derived Mesenchymal Stromal Cells Induce CD8+ Cytotoxic T Cell Reactivity |
| Q45342933 | Human Amnion-Derived Stem Cells Have Immunosuppressive Properties on NK Cells and Monocytes |
| Q42936902 | Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium. |
| Q45501605 | Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. |
| Q41832951 | Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. |
| Q37381922 | Human dental pulp stem cells cultured in serum-free supplemented medium |
| Q51252329 | Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. |
| Q34729151 | Human mesenchymal stem cell co-culture modulates the immunological properties of human intervertebral disc tissue fragments in vitro |
| Q34391664 | Human mesenchymal stem cell expression program upon extended ex-vivo cultivation, as revealed by 2-DE-based quantitative proteomics. |
| Q43254669 | Human mesenchymal stem cells and immunosuppressive drug interactions in allogeneic responses: an in vitro study using human cells |
| Q38139850 | Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors |
| Q37714452 | Human mesenchymal stem cells and their use in cell-based therapies. |
| Q50468624 | Human mesenchymal stem cells derived from bone marrow display a better chondrogenic differentiation compared with other sources. |
| Q35458958 | Human mesenchymal stem cells in contact with their environment: surface characteristics and the integrin system |
| Q36996120 | Human mesenchymal stem cells: from basic biology to clinical applications. |
| Q38048723 | Human mesenchymal stem cells: from immunophenotyping by flow cytometry to clinical applications |
| Q60394821 | Human mesenchymal stromal cells modulate T-cell responses through TNF-α-mediated activation of NF-κB |
| Q43222889 | Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. |
| Q52714547 | Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches. |
| Q37585427 | Humanized culture of periosteal progenitors in allogeneic serum enhances osteogenic differentiation and in vivo bone formation |
| Q53540450 | Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application. |
| Q28395211 | Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-β/SMAD2 and PI3K/Akt pathways |
| Q35870688 | Icariin stimulates the proliferation of rat bone mesenchymal stem cells via ERK and p38 MAPK signaling |
| Q90469288 | Identification of WNT16 as a Predictable Biomarker for Accelerated Osteogenic Differentiation of Tonsil-Derived Mesenchymal Stem Cells In Vitro |
| Q89885790 | Identification of neurospheres generated from human dental pulp stem cells in xeno-/serum-free conditions |
| Q55434861 | Immune Modulation by Mesenchymal Stem Cells. |
| Q64084531 | Immune Modulation by Transplanted Calcium Phosphate Biomaterials and Human Mesenchymal Stromal Cells in Bone Regeneration |
| Q36703067 | Immune regulation by mesenchymal stem cells: two sides to the coin |
| Q36737033 | Immune response to stem cells and strategies to induce tolerance |
| Q39723551 | Immunological characteristics of mesenchymal stem cells |
| Q41998193 | Immunological properties of embryonic and adult stem cells |
| Q37202800 | Immunomodulatory effect of mesenchymal stromal cells: possible mechanisms |
| Q73664290 | Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells |
| Q36990126 | Immunomodulatory effects of mesenchymal stromal cells revisited in the context of inflammatory cardiomyopathy |
| Q27026892 | Immunoregulation by mesenchymal stem cells: biological aspects and clinical applications |
| Q42000663 | Immunoregulatory effects of bone marrow-derived mesenchymal stem cells in the nasal polyp microenvironment. |
| Q36609696 | Immunoregulatory function of mesenchymal stem cells |
| Q38707655 | Impact of starting material (fresh versus cryopreserved marrow) on mesenchymal stem cell culture |
| Q36282399 | Impaired osteoblastogenesis in a murine model of dominant osteogenesis imperfecta: a new target for osteogenesis imperfecta pharmacological therapy. |
| Q38693545 | Implications of mesenchymal stem cells in regenerative medicine |
| Q38210863 | Improved human mesenchymal stem cell isolation. |
| Q39608956 | In Vivo Bioluminescence Imaging of Transplanted Mesenchymal Stromal Cells and Their Rejection Mediated by Intrahepatic NK Cells |
| Q34741419 | In utero therapy for congenital disorders using amniotic fluid stem cells |
| Q37271063 | In utero transplantation of adult bone marrow decreases perinatal lethality and rescues the bone phenotype in the knockin murine model for classical, dominant osteogenesis imperfecta |
| Q35832011 | In vitro analysis of integrin expression in stem cells from bone marrow and cord blood during chondrogenic differentiation |
| Q41083978 | In vitro expansion impaired the stemness of early passage mesenchymal stem cells for treatment of cartilage defects. |
| Q40246487 | In vitro transfection of plasmid DNA by cationized gelatin prepared from different amine compounds |
| Q34870479 | In vivo Differentiation Potential of Mesenchymal Stem Cells: Prenatal and Postnatal Model Systems. |
| Q35347210 | In vivo gene transfer into adult stem cells in unconditioned mice by in situ delivery of a lentiviral vector |
| Q90216409 | In vivo tracking of intravenously injected mesenchymal stem cells in an Alzheimer's animal model |
| Q42236941 | Inactivated human platelet lysate with psoralen: a new perspective for mesenchymal stromal cell production in Good Manufacturing Practice conditions. |
| Q39454582 | Informing future cartilage repair strategies: a comparative study of three different human cell types for cartilage tissue engineering |
| Q49715523 | Innate immune responses of equine monocytes cultured in equine platelet lysate |
| Q30415068 | Interferon gamma and T cells inhibit osteogenesis induced by allogeneic mesenchymal stromal cells |
| Q50509527 | Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway. |
| Q44878272 | Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy |
| Q37281919 | Intra-subject variability in human bone marrow stromal cell (BMSC) replicative senescence: molecular changes associated with BMSC senescence |
| Q27321287 | Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis |
| Q36290920 | Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts. |
| Q34534085 | Irradiation induces bone injury by damaging bone marrow microenvironment for stem cells. |
| Q52866935 | Isolation and Manufacture of Clinical-Grade Bone Marrow-Derived Human Mesenchymal Stromal Cells. |
| Q40516503 | Isolation and characterisation of mesenchymal stem cells from adult mouse bone marrow |
| Q41787137 | Isolation and therapeutic potential of human haemopoietic stem cells |
| Q81241941 | Isolation murine mesenchymal stem cells by positive selection |
| Q47347899 | Isolation, characterisation and osteogenic potential of human bone marrow stromal cells derived from the medullary cavity of the femur |
| Q61796570 | KIAA1199 is a secreted molecule that enhances osteoblastic stem cell migration and recruitment |
| Q35075538 | Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice |
| Q36738749 | Kupffer cells-dependent inflammation in the injured liver increases recruitment of mesenchymal stem cells in aging mice |
| Q36189956 | LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells |
| Q46754972 | Lactate modulates gene expression in human mesenchymal stem cells |
| Q35919694 | Lentivirus transduced interleukin-1 receptor antagonist gene expression in murine bone marrow-derived mesenchymal stem cells in vitro |
| Q37955704 | Lessons from genetically altered mesenchymal stem cells (MSCs): candidates for improved MSC-directed myocardial repair |
| Q45703658 | Light-activated gene transduction of recombinant adeno-associated virus in human mesenchymal stem cells |
| Q46670660 | Lipidomics of Mesenchymal Stromal Cells: Understanding the Adaptation of Phospholipid Profile in Response to Pro-Inflammatory Cytokines |
| Q42062735 | Local transplantation is an effective method for cell delivery in the osteogenesis imperfecta murine model |
| Q64116753 | Long noncoding RNA LINC00707 sponges miR-370-3p to promote osteogenesis of human bone marrow-derived mesenchymal stem cells through upregulating WNT2B |
| Q33634455 | Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients |
| Q42556916 | Low Oxygen Modulates Multiple Signaling Pathways, Increasing Self-Renewal, While Decreasing Differentiation, Senescence, and Apoptosis in Stromal MIAMI Cells |
| Q33527133 | Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells |
| Q84491370 | MSC for the improvement of hematopoietic engraftment |
| Q37781509 | MSCs: Biological characteristics, clinical applications and their outstanding concerns |
| Q39356606 | MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation |
| Q28079988 | Making the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell Expansion |
| Q39258533 | Malignant melanoma induces migration and invasion of adult mesenchymal stem cells |
| Q35030040 | Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. |
| Q89965054 | Management of Osteogenesis Imperfecta |
| Q39431469 | Manufacturing mesenchymal stromal cells for phase I clinical trials |
| Q64078455 | Mechanism of Action of Icariin in Bone Marrow Mesenchymal Stem Cells |
| Q36901342 | Mechanisms of immunomodulation by mesenchymal stem cells |
| Q28079649 | Mechanisms of mesenchymal stem/stromal cell function |
| Q51610305 | Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. |
| Q34475694 | Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials |
| Q89449438 | Mesenchymal Stem Cell Mediated Immuno-Modulatory and Anti-Inflammatory Mechanisms in Immune and Allergic Disorders |
| Q58720492 | Mesenchymal Stem Cell Therapy for Bone Regeneration |
| Q37690626 | Mesenchymal Stem Cell Therapy for Inflammatory Skin Diseases: Clinical Potential and Mode of Action |
| Q50733062 | Mesenchymal Stem Cells Attenuate the Adverse Effects of Immunosuppressive Drugs on Distinct T Cell Subopulations. |
| Q90056972 | Mesenchymal Stem Cells Beyond Regenerative Medicine |
| Q41635867 | Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis |
| Q36036209 | Mesenchymal Stem Cells from Human Extra Ocular Muscle Harbor Neuroectodermal Differentiation Potential. |
| Q41212597 | Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Can Preconditioning Strategies Improve Therapeutic Efficacy? |
| Q97519174 | Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers |
| Q40201999 | Mesenchymal cells |
| Q38038473 | Mesenchymal dental stem cells in regenerative dentistry. |
| Q41831728 | Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy |
| Q27007499 | Mesenchymal stem cell secretome and regenerative therapy after cancer |
| Q35971980 | Mesenchymal stem cell therapy in the treatment of acute and chronic graft versus host disease |
| Q26999783 | Mesenchymal stem cell transplantation in multiple sclerosis |
| Q37860414 | Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology |
| Q37427468 | Mesenchymal stem cell-based therapy for cartilage repair: a review. |
| Q35889077 | Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine |
| Q33719419 | Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus |
| Q83142880 | Mesenchymal stem cell-conditioned medium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays |
| Q55438460 | Mesenchymal stem cell-mediated Notch2 activation overcomes radiation-induced injury of the hematopoietic system. |
| Q58136326 | Mesenchymal stem cells |
| Q26753086 | Mesenchymal stem cells (MSCs) as skeletal therapeutics - an update |
| Q43408684 | Mesenchymal stem cells and endothelial progenitor cells stimulate bone regeneration and mineral density |
| Q38073795 | Mesenchymal stem cells and the lung. |
| Q33914228 | Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease |
| Q37390890 | Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. |
| Q42625406 | Mesenchymal stem cells as a potent cell source for bone regeneration. |
| Q33918923 | Mesenchymal stem cells as cellular vectors for pediatric neurological disorders |
| Q37707034 | Mesenchymal stem cells as therapeutic tools and gene carriers in liver fibrosis and hepatocellular carcinoma. |
| Q37138080 | Mesenchymal stem cells as therapeutics |
| Q34349428 | Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery |
| Q34676808 | Mesenchymal stem cells at the intersection of cell and gene therapy |
| Q54979810 | Mesenchymal stem cells attenuate blood-brain barrier leakage after cerebral ischemia in mice. |
| Q43833299 | Mesenchymal stem cells combined with barrier domes enhance vertical bone formation |
| Q37863214 | Mesenchymal stem cells derived from dental tissues. |
| Q40434694 | Mesenchymal stem cells facilitate fracture repair in an alcohol-induced impaired healing model |
| Q37606972 | Mesenchymal stem cells for bone repair and metabolic bone diseases. |
| Q38062875 | Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets? |
| Q29617267 | Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study |
| Q38272566 | Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis |
| Q82283820 | Mesenchymal stem cells improve small intestinal integrity through regulation of endogenous epithelial cell homeostasis |
| Q37668484 | Mesenchymal stem cells in alleviating sepsis-induced mice cardiac dysfunction via inhibition of mTORC1-p70S6K signal pathway |
| Q47123592 | Mesenchymal stem cells in idiopathic pulmonary fibrosis |
| Q36547852 | Mesenchymal stem cells in immunoregulation |
| Q37995014 | Mesenchymal stem cells in osteoarticular pediatric diseases: an update |
| Q38210869 | Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry |
| Q26743836 | Mesenchymal stem cells in regenerative rehabilitation |
| Q38127615 | Mesenchymal stem cells in the treatment of pediatric diseases |
| Q46622786 | Mesenchymal stem cells induce apoptosis of activated T cells |
| Q48617824 | Mesenchymal stem cells maintain blood-brain barrier integrity by inhibiting aquaporin-4 upregulation after cerebral ischemia |
| Q44486370 | Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. |
| Q53563416 | Mesenchymal stem cells stimulate antibody secretion in human B cells. |
| Q42133000 | Mesenchymal stem cells: From bench to bedside |
| Q34992277 | Mesenchymal stem cells: Molecular characteristics and clinical applications |
| Q37729093 | Mesenchymal stem cells: a new trend for cell therapy |
| Q35951877 | Mesenchymal stem cells: cell biology and potential use in therapy. |
| Q34422955 | Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. |
| Q37342808 | Mesenchymal stem/progenitor cells promote the reconstitution of exogenous hematopoietic stem cells in Fancg-/- mice in vivo |
| Q26825272 | Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy |
| Q47694971 | Mesenchymal stromal cell phenotype is not influenced by confluence during culture expansion |
| Q36629367 | Mesenchymal stromal cells |
| Q40567182 | Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model |
| Q37976114 | Mesenchymal stromal cells for tissue-engineered tissue and organ replacements |
| Q38206879 | Mesenchymal stromal cells in the antimicrobial host response of hematopoietic stem cell recipients with graft-versus-host disease--friends or foes? |
| Q35760116 | Mitochondrial function and energy metabolism in umbilical cord blood- and bone marrow-derived mesenchymal stem cells. |
| Q36795173 | Modulation of immune responses by mesenchymal stem cells |
| Q90327770 | Modulatory and regenerative potential of transplanted bone marrow-derived mesenchymal stem cells on rifampicin-induced kidney toxicity |
| Q39175513 | Molecular and Cellular Interactions of Allogenic and Autologus Mesenchymal Stem Cells with Innate and Acquired Immunity and Their Role in Regenerative Medicine |
| Q38157926 | Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. |
| Q37962744 | Molecular mediators of mesenchymal stem cell biology |
| Q37678413 | More insight into mesenchymal stem cells and their effects inside the body |
| Q34791234 | Multipotent Mesenchymal Stromal Cells for Autoimmune Diseases |
| Q37421286 | Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks. |
| Q36547021 | Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. |
| Q30478228 | Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. |
| Q46275076 | Murine mesenchymal stem cell isolated and expanded in low and high density culture system: surface antigen expression and osteogenic culture mineralization. |
| Q57777088 | Murine mesenchymal stem cells isolated by low density primary culture system |
| Q37591126 | Myogenic-induced mesenchymal stem cells are capable of modulating the immune response by regulatory T cells |
| Q34948033 | N-formyl-methionyl-leucyl-phenylalanine (fMLP) promotes osteoblast differentiation via the N-formyl peptide receptor 1-mediated signaling pathway in human mesenchymal stem cells from bone marrow |
| Q33258763 | N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. |
| Q57776854 | Nanotissue Engineering of Musculoskeletal Cells |
| Q36347990 | Neurorestoration induced by mesenchymal stem cells: potential therapeutic mechanisms for clinical trials. |
| Q37396444 | New era of cell-based orthopedic therapies. |
| Q58270335 | New frontiers for dominant osteogenesis imperfecta treatment: gene/cellular therapy approaches |
| Q37989396 | New insights on translational development of mesenchymal stromal cells for suppressor therapy |
| Q36144893 | Non-hematopoietic bone marrow stem cells: molecular control of expansion and differentiation |
| Q40339136 | Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs |
| Q61446442 | Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications |
| Q34582606 | One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. |
| Q33456591 | Optimizing isolation culture and freezing methods to preserve Wharton's jelly's mesenchymal stem cell (MSC) properties: an MSC banking protocol validation for the Hellenic Cord Blood Bank. |
| Q89359657 | Origin of Reparative Stem Cells in Fracture Healing |
| Q33713231 | Orthopedic gene therapy in 2008. |
| Q41493518 | Osmotic behaviour of human mesenchymal stem cells: Implications for cryopreservation |
| Q35932671 | Osteogenesis Imperfecta: A Review with Clinical Examples. |
| Q34316613 | Osteogenesis imperfecta |
| Q39062996 | Osteogenic Differentiation in Healthy and Pathological Conditions |
| Q42957949 | Osteogenic and adipogenic cell fractions isolated from postnatal mouse calvaria |
| Q36035697 | Osteogenic differentiation of mesenchymal stromal cells in two-dimensional and three-dimensional cultures without animal serum |
| Q53000571 | Ovariectomized Rats with Established Osteopenia have Diminished Mesenchymal Stem Cells in the Bone Marrow and Impaired Homing, Osteoinduction and Bone Regeneration at the Fracture Site. |
| Q47245037 | PEG hydrogel containing calcium-releasing particles and mesenchymal stromal cells promote vessel maturation |
| Q34501852 | Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1. |
| Q40099637 | Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells |
| Q34204513 | Periurethral injection of autologous adipose-derived regenerative cells for the treatment of male stress urinary incontinence: Report of three initial cases |
| Q38078084 | Perivascular mesenchymal stem cells in the adult human brain: a future target for neuroregeneration? |
| Q34581991 | Persistence of intracellular and extracellular changes after incompletely suppressing expression of the R789C (p.R989C) and R992C (p.R1192C) collagen II mutants |
| Q34768188 | Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells |
| Q35242096 | Phenotypic and functional characterization of human bone marrow stromal cells in hollow-fibre bioreactors |
| Q34751358 | Placental mesenchymal stromal cells derived from blood vessels or avascular tissues: what is the better choice to support endothelial cell function? |
| Q52642345 | Platelet lysate as a novel serum-free media supplement for the culture of equine bone marrow-derived mesenchymal stem cells. |
| Q53288262 | Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. |
| Q42242005 | Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of activ |
| Q47783595 | Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors |
| Q37257628 | Poly(ε-caprolactone)-carbon nanotube composite scaffolds for enhanced cardiac differentiation of human mesenchymal stem cells |
| Q33863266 | Potential implications of cell therapy for osteogenesis imperfecta |
| Q37523900 | Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta |
| Q37315399 | Potential role of mesenchymal stromal cells in pediatric hematopoietic SCT. |
| Q37585445 | Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience |
| Q64926918 | Preconditioning in an Inflammatory Milieu Augments the Immunotherapeutic Function of Mesenchymal Stromal Cells. |
| Q34312131 | Prenatal transplantation of mesenchymal stem cells to treat osteogenesis imperfecta |
| Q28757126 | Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 |
| Q51009753 | Profiling and semiquantitative analysis of the cell surface proteome in human mesenchymal stem cells. |
| Q34480435 | Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome |
| Q36050692 | Properties of mechano-transduction via simulated microgravity and its effects on intracellular trafficking of VEGFR's |
| Q36275783 | Prospects and limitations of improving skeletal growth in a mouse model of spondyloepiphyseal dysplasia caused by R992C (p.R1192C) substitution in collagen II. |
| Q30431697 | Prospects for osteoprogenitor stem cells in fracture repair and osteoporosis |
| Q47274328 | Prospects of Pluripotent and Adult Stem Cells for Rare Diseases. |
| Q34548370 | Prostacyclin suppresses twist expression in the presence of indomethacin in bone marrow-derived mesenchymal stromal cells. |
| Q41767093 | Rapid growth and osteogenic differentiation of mesenchymal stem cells isolated from human bone marrow |
| Q26824117 | Recent advances in bone regeneration using adult stem cells |
| Q26781674 | Recent developments in osteogenesis imperfecta |
| Q37947153 | Recent progress in osteogenesis imperfecta |
| Q33588206 | Recipient Glycemic Micro-environments Govern Therapeutic Effects of Mesenchymal Stem Cell Infusion on Osteopenia |
| Q33711085 | Recommendations and considerations for the use of biologics in orthopedic surgery |
| Q38131118 | Reconciling the effects of inflammatory cytokines on mesenchymal cell osteogenic differentiation |
| Q64096010 | Reduction of Inflammation and Enhancement of Motility after Pancreatic Islet Derived Stem Cell Transplantation Following Spinal Cord Injury |
| Q43375908 | Regulation of Osteogenic Differentiation of Placental-Derived Mesenchymal Stem Cells by Insulin-Like Growth Factors and Low Oxygen Tension. |
| Q64099263 | Regulation of Redox Homeostasis by Nonthermal Biocompatible Plasma Discharge in Stem Cell Differentiation |
| Q35222931 | Rejuvenation: an integrated approach to regenerative medicine |
| Q53272398 | Repair of bone defect with vascularized tissue engineered bone graft seeded with mesenchymal stem cells in rabbits. |
| Q45855295 | Restoration of cellular function of mesenchymal stem cells from a hypophosphatasia patient |
| Q89133396 | Retrieval of a periodontally compromised tooth by allogeneic grafting of mesenchymal stem cells from dental pulp: A case report |
| Q37976449 | Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells |
| Q26825380 | Role of mesenchymal stem cells in bone regeneration and fracture repair: a review |
| Q46284858 | Runx2/Cbfa1-genetically engineered skeletal myoblasts mineralize collagen scaffolds in vitro |
| Q42689394 | Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials. |
| Q57289629 | Secretion of angiogenic proteins by human multipotent mesenchymal stromal cells and their clinical potential in the treatment of avascular osteonecrosis |
| Q33814461 | Secretome from mesenchymal stem cells induces angiogenesis via Cyr61 |
| Q37294609 | Sequential use of human-derived medium supplements favours cardiovascular tissue engineering. |
| Q43239856 | Serial in vivo imaging of the porcine heart after percutaneous, intramyocardially injected 111In-labeled human mesenchymal stromal cells |
| Q34997877 | Serial transplantation and long-term engraftment of intra-arterially delivered clonally derived mesenchymal stem cells to injured bone marrow. |
| Q39012336 | Serum albumin as a local therapeutic agent in cell therapy and tissue engineering. |
| Q38151905 | Serum-free media for the production of human mesenchymal stromal cells: a review. |
| Q50583284 | Serum-free medium with osteogenic supplements induces adipogenesis in rat bone marrow stromal cells. |
| Q37368244 | Serum-free spheroid suspension culture maintains mesenchymal stem cell proliferation and differentiation potential |
| Q57282139 | Short-term physiological hypoxia potentiates the therapeutic function of mesenchymal stem cells |
| Q26778170 | Skeletal stem cells and their contribution to skeletal fragility: senescence and rejuvenation |
| Q36159300 | Skeletal stem cells in regenerative medicine |
| Q37111537 | Small molecules affect human dental pulp stem cell properties via multiple signaling pathways |
| Q36771332 | Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke |
| Q35146617 | Sources of adult mesenchymal stem cells applicable for musculoskeletal applications - a systematic review of the literature |
| Q43944175 | Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. |
| Q38175402 | Specific protein markers for stem cell cross-talk with neighboring cells in the environment |
| Q35982861 | Spontaneous Differentiation of Human Mesenchymal Stem Cells on Poly-Lactic-Co-Glycolic Acid Nano-Fiber Scaffold |
| Q33765265 | Stem Cell Therapy: A New Treatment for Burns? |
| Q34343825 | Stem Cells and Regenerative Medicine: Accomplishments to Date and Future Promise |
| Q34150828 | Stem cell bioprocess engineering towards cGMP production and clinical applications |
| Q36990671 | Stem cell differentiation and expansion for clinical applications of tissue engineering |
| Q38160451 | Stem cell horizons in intervertebral disc degeneration |
| Q36729785 | Stem cell myths |
| Q37754873 | Stem cell therapy for cystic fibrosis: current status and future prospects |
| Q38331002 | Stem cell therapy for inflammatory bowel disease |
| Q36150403 | Stem cell therapy for osteonecrosis of the femoral head |
| Q37161090 | Stem cell therapy for voiding and erectile dysfunction |
| Q38472909 | Stem cell transplantation before birth - a realistic option for treatment of osteogenesis imperfecta? |
| Q37734210 | Stem cell transplantation in multiple sclerosis: current status and future prospects |
| Q35568777 | Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells |
| Q35923390 | Stem cell- and growth factor-based regenerative therapies for avascular necrosis of the femoral head |
| Q38736047 | Stem cells applications in bone and tooth repair and regeneration: New insights, tools, and hopes |
| Q37730300 | Stem cells as vectors for antitumour therapy |
| Q37143887 | Stem cells bioprocessing: an important milestone to move regenerative medicine research into the clinical arena |
| Q34961663 | Stem cells derived from amniotic fluid: new potentials in regenerative medicine |
| Q51910330 | Stem cells genetically modified with the developmental gene MT1-MMP improve regeneration of the supraspinatus tendon-to-bone insertion site. |
| Q91688583 | Stem cells in Osteoporosis: From Biology to New Therapeutic Approaches |
| Q53290264 | Stromal cell-derived factor-1 mediates changes of bone marrow stem cells during the bone repair process. |
| Q34614799 | Stromal cell-derived factor-1β mediates cell survival through enhancing autophagy in bone marrow-derived mesenchymal stem cells. |
| Q90733778 | Suitability and limitations of mesenchymal stem cells to elucidate human bone illness |
| Q36905079 | Suppression of androgen receptor enhances the self-renewal of mesenchymal stem cells through elevated expression of EGFR. |
| Q51545691 | Suppression of human peripheral blood lymphocyte proliferation by immortalized mesenchymal stem cells derived from bone marrow of Banna Minipig inbred-line. |
| Q38982780 | Sustained expression of coagulation factor IX by modified cord blood-derived mesenchymal stromal cells |
| Q33864378 | Synovium fragment-derived cells exhibit characteristics similar to those of dissociated multipotent cells in synovial fluid of the temporomandibular joint |
| Q51349416 | Synthetic vascular prosthesis impregnated with genetically modified bone marrow cells produced recombinant proteins. |
| Q36808571 | Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related Osteoporosis |
| Q37692465 | Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures. |
| Q37307155 | TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation |
| Q56574797 | THIS ARTICLE HAS BEEN RETRACTED Periurethral injection of autologous adipose‐derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: Report of two initial cases |
| Q30449821 | Targets and delivery methods for therapeutic angiogenesis in peripheral artery disease |
| Q39898293 | Telomerase immortalized human amnion- and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristics. |
| Q37071096 | The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice |
| Q34760856 | The Cdc42 guanine nucleotide exchange factor FGD1 regulates osteogenesis in human mesenchymal stem cells |
| Q47224539 | The Components of Bone and What They Can Teach Us about Regeneration |
| Q52661742 | The Effects of Photobiomodulation of 808 nm Diode Laser Therapy at Higher Fluence on the in Vitro Osteogenic Differentiation of Bone Marrow Stromal Cells. |
| Q26773017 | The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis |
| Q37758303 | The Oncogenic Potential of Mesenchymal Stem Cells in the Treatment of Cancer: Directions for Future Research |
| Q89623527 | The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses |
| Q56837269 | The Safety of Non-Expanded Multipotential Stromal Cell Therapies |
| Q36804648 | The concept of mesenchymal stem cells |
| Q81434774 | The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update |
| Q42124688 | The effect of in vivo mobilization of bone marrow stem cells on the pancreas of diabetic albino rats (a histological & immunohistochemical study). |
| Q33941513 | The effects of axial displacement on fracture callus morphology and MSC homing depend on the timing of application |
| Q33630408 | The efficacy of human placenta-derived mesenchymal stem cells on radiation enteropathy along with proteomic biomarkers predicting a favorable response |
| Q35940531 | The elusive nature and function of mesenchymal stem cells |
| Q33454406 | The establishment of a bank of stored clinical bone marrow stromal cell products |
| Q45876004 | The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells |
| Q37310625 | The immune boundaries for stem cell based therapies: problems and prospective solutions. |
| Q36715937 | The impact of cell source, culture methodology, culture location, and individual donors on gene expression profiles of bone marrow-derived and adipose-derived stromal cells. |
| Q37720654 | The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine |
| Q37567542 | The possible use of stem cells in regenerative medicine: dream or reality? |
| Q37790311 | The potential of adipose stem cells in regenerative medicine. |
| Q36054671 | The potential of mesenchymal stromal cells as a novel cellular therapy for multiple sclerosis |
| Q45222224 | The role of bone marrow-derived cells during the bone healing process in the GFP mouse bone marrow transplantation model. |
| Q38150244 | The role of mesenchymal stem cells in bone repair and regeneration |
| Q38788475 | The role of mesenchymal stem cells in oncology and regenerative medicine |
| Q36268038 | The role of recipient T cells in mesenchymal stem cell-based tissue regeneration |
| Q39852962 | The small molecule phenamil induces osteoblast differentiation and mineralization |
| Q37677911 | The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group |
| Q36897375 | The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy |
| Q89769517 | Therapeutic Mesenchymal Stromal Cells for Immunotherapy and for Gene and Drug Delivery |
| Q37142832 | Therapeutic angiogenesis in critical limb ischemia. |
| Q38057676 | Therapeutic application of mesenchymal stem cells in bone and joint diseases |
| Q30319123 | Therapeutic application of mesenchymal stromal cells in autoimmune disease: rationale and initial clinical experience |
| Q38213836 | Therapeutic cell carriers: a potential road to cure glioma |
| Q34159047 | Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton |
| Q34137317 | Therapeutic potential of genetically modified adult stem cells for osteopenia |
| Q36737833 | Therapeutic potential of mesenchymal stem cells in regenerative medicine |
| Q35726548 | Therapeutic potential of stem cells in orthopedics |
| Q46643273 | Therapeutic superiority for cartilage repair by CD271-positive marrow stromal cell transplantation |
| Q37669198 | Tissue Engineering with Nano-Fibrous Scaffolds |
| Q51094994 | Tissue engineering using adult stem cells. |
| Q80568647 | Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon |
| Q37164045 | Tolerance strategies for stem-cell-based therapies. |
| Q34652682 | Total body irradiation is permissive for mesenchymal stem cell-mediated new bone formation following local transplantation. |
| Q38127722 | Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies. |
| Q36183143 | Transcription factor ZNF25 is associated with osteoblast differentiation of human skeletal stem cells |
| Q33952249 | Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells |
| Q34557484 | Translating research into clinical scale manufacturing of mesenchymal stromal cells |
| Q60912266 | Transplantation of bone marrow mesenchymal stromal cells attenuates liver fibrosis in mice by regulating macrophage subtypes |
| Q36206449 | Transplanted bone marrow mononuclear cells and MSCs impart clinical benefit to children with osteogenesis imperfecta through different mechanisms. |
| Q36915154 | Transplanted murine long-term repopulating hematopoietic cells can differentiate to osteoblasts in the marrow stem cell niche |
| Q36656538 | Treatment of children with osteogenesis imperfecta |
| Q26853357 | Treatment of osteogenesis imperfecta in adults |
| Q37194001 | Treatment of systemic sclerosis: potential role for stem cell transplantation. |
| Q58752199 | Treatment options for osteogenesis imperfecta |
| Q42596943 | True autologous approach in cell therapy. - Using your own serum for cell culture -. |
| Q50215039 | UV-activated 7-dehydrocholesterol-coated titanium implants promote differentiation of human umbilical cord mesenchymal stem cells into osteoblasts |
| Q37721514 | Unrelated donor allogeneic hematopoietic stem cell transplantation for patients with hemoglobinopathies using a reduced-intensity conditioning regimen and third-party mesenchymal stromal cells |
| Q38924988 | Use of Pig as a Model for Mesenchymal Stem Cell Therapies for Bone Regeneration. |
| Q26747035 | Using Stem Cells to Grow Artificial Tissue for Peripheral Nerve Repair |
| Q26777025 | Using mesenchymal stem cells as a therapy for bone regeneration and repairing |
| Q47401296 | VEGF secreted by mesenchymal stem cells mediates the differentiation of endothelial progenitor cells into endothelial cells via paracrine mechanisms |
| Q38293045 | Virus-based scaffolds for tissue engineering applications |
| Q37542905 | Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis |
| Q36728535 | Xeno-Free Extraction, Culture, and Cryopreservation of Human Adipose-Derived Mesenchymal Stem Cells |
| Q42577722 | Xeno-free chondrogenesis of bone marrow mesenchymal stromal cells: towards clinical-grade chondrocyte production. |
| Q80988331 | [Bone harvesting from the iliac crest] |
| Q88040135 | [Mesenchymal stem/stroma cells : Therapeutic potential in the treatment of autoimmune diseases] |
| Q83514683 | [Mesenchymal stromal cells: Biological properties and clinical prospects] |
| Q80357363 | [The hopes of the mesenchymal stem cells in regenerative medicine] |
| Q50464926 | hTERT- and hCTLA4Ig-expressing human bone marrow-derived mesenchymal stem cells: in vitro and in vivo characterization and osteogenic differentiation. |
Search more.